
Childhood cancer survivors are at high risk of late adverse effects of cancer treatment, but there are still many gaps in evidence about these late zzso We described the methodology, clinical zzso data zzso and outcomes of our cohort study of childhood cancer zzso 

The Emma Children's zzso Medical Center zzso childhood cancer zzso cohort is an ongoing zzso cohort study of zzso childhood cancer survivors, which started in 1996 simultaneously with regular structured medical outcome assessments at our zzso zzso 

From 1966 to 2003, zzso eligible children received primary cancer treatment in the zzso of which zzso zzso survived zzso since zzso zzso time ranged from zzso to zzso zzso zzso zzso primary cancer treatment characteristics were complete for zzso zzso survivors, and zzso zzso survivors visited our zzso zzso zzso characteristics of survivors who visited the clinic did not differ from those without zzso Within our zzso 54 studies have been conducted studying a wide range of late zzso zzso 

The zzso childhood cancer zzso cohort provides a strong structure for ongoing research on the late effects of childhood cancer treatment and will continuously contribute in reducing evidence gaps concerning risks and risk groups within this vulnerable zzso 

Our large cohort study of childhood cancer survivors with complete baseline characteristics and unique, long-term medical follow-up decreases gaps in evidence about specific risks of late effects and high-risk groups, with the ultimate goal of improving the quality of care for childhood cancer zzso 

